These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10419404)

  • 21. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children.
    Fabris A; Catamo E; Segat L; Morgutti M; Arraes LC; de Lima-Filho JL; Crovella S
    AIDS; 2009 Jan; 23(2):177-82. PubMed ID: 19098486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.
    John M; Moore CB; James IR; Mallal SA
    Antivir Ther; 2005; 10(4):551-5. PubMed ID: 16038481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of human leukocyte antigen E and G in HIV infection.
    Tripathi P; Agrawal S
    AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
    [No Abstract]   [Full Text] [Related]  

  • 24. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
    Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
    Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding the genetic diversity of HIV-1.
    McCutchan FE
    AIDS; 2000; 14 Suppl 3():S31-44. PubMed ID: 11086847
    [No Abstract]   [Full Text] [Related]  

  • 27. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
    Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
    Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of HIV to AIDS: a protective role for HLA-B27?
    den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
    AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Host genetic polymorphisms in the pathogenesis of HIV-1 infection].
    Shioda T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):89-93. PubMed ID: 11963186
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune control of HIV: the obstacles of HLA and viral diversity.
    Walker BD; Korber BT
    Nat Immunol; 2001 Jun; 2(6):473-5. PubMed ID: 11376327
    [No Abstract]   [Full Text] [Related]  

  • 31. [Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].
    Zúñiga J; Vargas-Alarcón G; Salgado N; Flores C; Martínez-Tripp S; Miranda A; Balbuena A; Osnaya N; Juárez F; Granados J; Reyes-Terán G
    Rev Invest Clin; 2000; 52(3):284-95. PubMed ID: 10953612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV genetic diversity and its consequences].
    Roquebert B; Damond F; Brun-Vézinet F; Descamps D
    Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic diversity of HIV-1: the moving target.
    Peeters M; Sharp PM
    AIDS; 2000; 14 Suppl 3():S129-40. PubMed ID: 11086856
    [No Abstract]   [Full Text] [Related]  

  • 35. [HIV-1 genetic variability in non Spaniard infected children].
    Piñeiro Pérez R; Mellado Peña MJ; Holguín A; Cilleruelo MJ; García Hortelano M; Villota J; Martín Fontelos P
    An Pediatr (Barc); 2009 Jan; 70(1):20-6. PubMed ID: 19174115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO+CD4+ T lymphocytes.
    Holl V; Schmidt S; Aubertin AM; Moog C
    Arch Virol; 2007; 152(3):507-18. PubMed ID: 17122895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
    Brumme ZL; Brumme CJ; Chui C; Mo T; Wynhoven B; Woods CK; Henrick BM; Hogg RS; Montaner JS; Harrigan PR
    J Infect Dis; 2007 Jun; 195(11):1694-704. PubMed ID: 17471440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV [corrected] genetic diversity surveillance in the United States.
    Bennett D
    J Infect Dis; 2005 Jul; 192(1):4-9. PubMed ID: 15942886
    [No Abstract]   [Full Text] [Related]  

  • 39. A new look at human leukocyte antigen variation in HIV; functional clustering to enhance power for discovery of host genetic associations.
    McLaren PJ
    AIDS; 2023 Sep; 37(11):1757-1758. PubMed ID: 37534725
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV and HLA: confusion or complexity?
    Hill AV
    Nat Med; 1996 Apr; 2(4):395-6. PubMed ID: 8597943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.